Clinical outcomes associated with ACE inhibitors and ARBs use in adults older than 85 years who recovered from dialysis‐requiring acute kidney injury
Among very old adults after dialysis for AKI, the ACEi/ARB therapy was significantly associated with lower risks of all-cause mortality and MAKE, but with a significantly increased risk of hypotension and hyperkalaemia. These findings support the cautious use of ACEi/ARB in this high-risk population.
Authors
- Chung‐Yi Li (ORCID: https://orcid.org/0000-0002-0321-8908)
- Jui‐Yi Chen (ORCID: https://orcid.org/0000-0003-1376-7780)
Institutions
- Asia University (TW)
- China Medical University (TW)
- Ministry of Health and Welfare (TW)
- Chi Mei Medical Center (TW)
- Chia Nan University of Pharmacy and Science (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1002/bcp.70408
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00